Related Articles
Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma
Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study
Phase II study on the combination of irinotecan plus cisplatin as a second‑line therapy in patients with advanced or recurrent gastric cancer
Phase I/II study of combination therapy with S-1 and CPT-11 for metastatic colorectal cancer
A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer